Bottom line
WEBL vs LABU: the short answer
WEBL (Direxion Daily Dow Jones Internet Bull 3X ETF) and LABU (Direxion Daily S&P Biotech Bull 3X ETF) are both etfs.
But LABU is far broader, holding 163 positions to 47 for WEBL, so beyond the top names it adds exposure WEBL doesn't have.
Both charge the same expense ratio (0.96%).
Over five years, WEBL returned −15.0% a year vs −39.6% for LABU.
Updated Nov 19, 2026
WEBL vs LABU side by side
| WEBL | LABU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.96% | 0.96% |
| Annual cost per $10k | $96 | $96 |
| 10-yr cost on $10k (prospectus) | $1,178 | $1,178 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.5% | +78.7% |
| 5-yr return (annualized) | −15.0% | −39.6% |
| 10-yr return (annualized) | — | −20.8% |
| Best quarter | +141.4% | +161.5% |
| Worst quarter | −74.6% | −67.4% |
| Net assets (fund) | $93.5M | $494.4M |
| Number of holdings | 47 | 163 |
| Portfolio turnover | 6% | 107% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | WEBL | LABU | Difference |
|---|---|---|---|
| 2025 | +2.5% | +78.7% | −76.2% |
| 2024 | +76.6% | −25.9% | +102.5% |
| 2023 | +165.6% | −13.4% | +179.1% |
| 2022 | −91.0% | −80.3% | −10.7% |
| 2021 | +2.8% | −64.3% | +67.1% |
| 2020 | +131.8% | +74.7% | +57.1% |
Source: Fund prospectus bar charts
Holdings overlap
4 of WEBL's top 25 holdings also appear in LABU's top 25.
| Holding | WEBL | LABU |
|---|---|---|
| Dreyfus | 19.77% | 15.86% |
| Goldman Financial | 11.86% | 14.83% |
| N/a | 10.83% | 3.87% |
| N/a | 4.39% | 3.87% |
Source: SEC Form N-PORT
WEBL top 10
- Dreyfus — 19.77%
- Goldman Financial — 11.86%
- N/a — 10.83%
- Amazon.com Inc — 7.08%
- Meta Platforms Inc — 6.05%
- Cisco Systems Inc — 5.25%
- N/a — 4.39%
- Alphabet Inc — 3.45%
- Booking Holdings Inc — 3.35%
- Arista Networks Inc — 3.32%
LABU top 10
- Dreyfus — 15.86%
- Goldman Financial — 14.83%
- N/a — 9.63%
- N/a — 7.30%
- Goldman Sachs Liq Es Fd A — 5.35%
- N/a — 4.85%
- N/a — 3.87%
- Apogee Therapeutics Inc — 1.11%
- Oruka Therapeutics Inc — 1.03%
- Dianthus Therapeutics Inc — 0.96%
FAQ
What is the difference between WEBL and LABU?
Which is cheaper, WEBL or LABU?
Should I own both WEBL and LABU?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.